News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merit Medical Systems, Inc. (MMSI) Gets FDA's Highest-Risk Label Over Hospira, Inc. Injections



3/14/2014 7:06:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FDA regulators put their highest-risk label on Merit Medical's recall of kits containing 1% Lidocaine HCl injections manufactured by Hospira. FDA officials put their highest-risk Class I label on a recall of certain Merit Medical Systems (NSDQ:MMSI) procedural trays and kits over concerns about 1% Lidocaine HCl injections manufactured by Hospira (NYSE:HSP). he injections were recalled after 1 confirmed customer report of red and black particulate in the container, according to the FDA memo.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES